| Literature DB >> 26247479 |
Lingling Zhai1, Jihong Liu2, Jian Zhao3, Junxiu Liu2, Yinglong Bai1, Lihong Jia1, Xingjia Yao1.
Abstract
OBJECTIVE: To examine the influence of childhood obesity on the early onset of puberty and sex hormones in girls.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26247479 PMCID: PMC4527677 DOI: 10.1371/journal.pone.0134656
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Characteristics of study population at baseline (n = 120, 40/group).
| Obese | Normal | Lean |
| |
|---|---|---|---|---|
| School ID, n (%) | 0.087 | |||
| 1 | 20(48.8%) | 8(19.5%) | 13(31.7%) | |
| 2 | 12(24.5%) | 20(40.8%) | 17(34.7%) | |
| 3 | 8(26.7%) | 12(40%) | 10(33.3%) | |
| Age (mean±SD, y) | 8.6±0.3 | 8.6±0.3 | 8.5±0.4 | 0.732 |
| Height (mean±SD, cm) | 133.2±4.9 | 132.5±4.9 | 132.6±5.1 | 0.761 |
| Weight (mean±SD, kg) | 36.9±7.6 | 28.6±3.0 | 24.3±2.5 | 0.000 |
| BF% (mean±SD) | 26.4±3.4 | 17.9±1.5 | 14.1±0.9 | 0.000 |
| Age at breast II (95% C.I.) | 8.8(8.6–8.9) | 9.2(8.9–9.5) | 9.3(8.9–9.6) | 0.023 |
| Stage of Breast, n (%) | 1.000 | |||
| I | 27(67.5%) | 27(67.5%) | 27(67.5%) | |
| II | 13(32.5%) | 13(32.5%) | 13(32.5%) |
a. Obese, normal, and lean groups were classified according to body fat percent (%) using skinfold thickness.
b. Chi square test of independence were used to compare the difference among the three groups.
c. ANOVA and least significant difference (LSD) analyses were used to compare the means among the three groups.
d. Post hoc tests were used to compare the difference between obese, normal, and lean girls. The mean age at breast II onset was earlier in obese girls than normal (P = 0.04) and lean girls(P = 0.02).
Stage of breast development in girls during 4 years of follow-up, n*(%).
| Group | Year 1 | Year 2 | Year 3 | Year 4 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | II | I | II | III | I | II | III | I | II | III | IV | |
| Obese | 27(67.5%) | 13(32.5%) | 4(10.0%) | 36(90.0%) | 0(0.0%) | 1(2.5%) | 24(60.0%) | 15(37.5%) | 0(0.0%) | 10(25.6%) | 20(51.3%) | 9(23.1%) |
| Normal | 27(67.5%) | 13(32.5%) | 16(41.0%) | 22(56.4%) | 1(2.6%) | 6(15.0%) | 18(45.0%) | 16(40.0%) | 0(0.0%) | 12(30.0%) | 22(55.0%) | 6(15.0%) |
| Lean | 27(67.5%) | 13(32.5%) | 19(47.5%) | 20(50.0%) | 1(2.5%) | 7(17.9%) | 26(66.7%) | 6(15.4%) | 1(2.7%) | 22(5.95%) | 13(35.1%) | 1(2.7%) |
a: The percentage of girls who were in different breast stages was significantly different in the three groups (P = 0.001, chi-square test). The percentage of obese girls who were in breast stage II and above was significantly higher than those among normal and lean girls (P = 0.002, P = 0.000, chi-square test).
b:The percentage of girls who were in different breast stages was significantly different in the three groups (P = 0.028, chi-square test). The percentage of obese girls who were in breast stage II and above was higher than those in lean girls (P = 0.023, chi-square test).
c:The percentage of girls who were in different breast stages was significantly different in the three groups (P = 0.012, chi-square test). The percentage of obese girls who were in breast stage III and above was significantly higher than those in lean girls (P = 0.001, chi-square test). The percentage of normal girls who were in breast stage III and above was significantly higher than those in lean girls (P = 0.005, chi-square test).
*: Sample sizes for Year 1 were n = 40 girls in each of three groups.
Sample sizes for Year 2 were n = 40 for obese and lean groups, respectively, n = 39 for normal group.
Sample sizes for Year 3 were n = 40 for obese and normal groups, respectively, n = 39 (lean group).
sample sizes for Year 4 were n = 39 (obese), n = 40 (normal) n = 36 (lean).
Relative Risks and 95% Confidence Intervals for being breast II and above during the 4 years.
| Covariates | RR(95%CI) | |||
|---|---|---|---|---|
| Year 1 | Year 2 | Year 3 | Year 4 | |
| Obese vs Normal | 1.0 (0.4–2.6) | 6.3 (1.9–21.1) | 6.9(0.8–60.1) | — |
| Lean vs Normal | 1.0 (0.4–2.6) | 0.9 (0.4–2.3) | 0.8 (0.3–2.7) | — |
Abbreviations: CI, confidence interval
a: P<0.05
b: We did not show the 95% CIs of Year 4 due to zero cell in year 4.
Generalized Linear Model (GLM) for repeated measures: estradiol and testosterone by baseline group status.
| Source | DF | Type III SS | Mean Square | F value | P-value | |
|---|---|---|---|---|---|---|
| Estradiol | Group | 2 | 300621.5 | 150310.7 | 20.2 | <.0001 |
| Time | 3 | 2104878.3 | 701626.1 | 138.5 | <.0001 | |
| Interaction | 6 | 60157.3 | 10026.2 | 2.0 | 0.0657 | |
| Testosterone | Group | 2 | 12.9 | 6.4 | 0.9 | 0.4208 |
| Time | 3 | 591.1 | 197.0 | 34.7 | <.0001 | |
| Interaction | 6 | 142.9 | 23.8 | 4.2 | 0.0003 |
Fig 1Changes in estradiol levels in girls in the 4 years.
a: The trend level of estradiol in obese girls was significantly higher than that in normal weight girls (P = 0.043). b: The trend level of estradiol in obese girls was significantly higher than that in lean girls (P = 0.003).
Fig 2Changes in testosterone levels in girls in the 4 years.
a: The testosterone level in obese girls was significantly higher than that in the normal girls (P = 0.04).